Roche/Genentech’s Gazyva Poised to Transform Lupus Nephritis Treatment After Positive Phase III Results
October 10, 2024 10:28 ET
|
Spherix Global Insights
EXTON, PA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a...
UXUY Implements Bitcoin Lightning Node to Serve Multi-Chain Trading for Taproot Assets
October 13, 2023 05:40 ET
|
UXUY
Singapore, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Today 13th of October, 2023, the next-generation decentralized trading platform UXUY will officially implement the Bitcoin Lightning Network node named...
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
February 26, 2019 16:07 ET
|
Equillium
Clinical trial evaluating EQ001 for the treatment of refractory lupus nephritis to commence in 2H 2019 Ongoing EQ001 development programs in acute graft-versus-host disease and severe asthma remain...